BioSpace News Archive

Press Releases

Vir Biotechnology Reports Third Quarter 2024 Financial Results and Provides Corporate Update

October 31, 2024
·
17 min read
Press Releases

ChromaDex Corporation Reports Third Quarter 2024 Financial Results

October 31, 2024
·
15 min read
Press Releases

Arcturus Therapeutics to Report Third Quarter Financial Results and Provide Corporate Update on November 7, 2024

October 31, 2024
·
1 min read
Press Releases

Verastem Oncology Completes Rolling NDA Submission to the FDA for Avutometinib Plus Defactinib as a Treatment for Recurrent KRAS Mutant Low-Grade Serous Ovarian Cancer

October 31, 2024
·
13 min read
Press Releases

Adaptimmune to Report Q3 2024 Financial and Business Updates on Wednesday, November 13, 2024

October 31, 2024
·
2 min read
Press Releases

Bexion Pharmaceuticals, Inc. Announces Publication of Phase 1 Data for BXQ-350 in Advanced Solid Tumors

October 31, 2024
·
3 min read
Press Releases

Nektar to Announce Financial Results for the Third Quarter 2024 on Thursday, November 7, 2024, After Close of U.S.-Based Financial Markets

October 31, 2024
·
1 min read
Press Releases

Lexicon Announces Outcome of FDA Advisory Committee for Zynquista™ (sotagliflozin) as an Adjunct to Insulin Therapy for Glycemic Control in Adults with Type 1 Diabetes and Chronic Kidney Disease

October 31, 2024
·
5 min read
Press Releases

Eisai Completes Rolling Submission to US FDA for LEQEMBI® (lecanemab-irmb) Biologics License Application for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Under the Fast Track Status

October 31, 2024
·
19 min read
Press Releases

ESSA Pharma Announces Termination of Phase 2 Study Evaluating Masofaniten Combined with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer

October 31, 2024
·
8 min read